It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2008.
2008 | Mumbai, Maharashtra, India | ActiveHyrio Laboratories Private Limited, a active private limited company, was established on 29 July 2008 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U51397MH2008PTC185185. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.70 M.
It upholds a compliant status. Its leadership includes Neeta Arvind Mishra (Director), Divya Nanak Bajaj (Managing Director). Past directors included Rohini Mariam Alexander. It holds ₹5.72 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 302, Swastik Disa Corporate Park , L. B. S. Marg., Opp. Shreyas Cinema, Ghatkopar (W),, Mumbai, Maharashtra, 400086.
U51397MH2008PTC185185
185185
29 July 2008
₹2.50 M
₹0.70 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Hyrio Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeta Arvind Mishra | Director | 04 Oct 2008 | Current |
| Divya Nanak Bajaj | Managing Director | 29 Jul 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Oct 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hyrio Laboratories Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 97.95% decrease. The company also saw a substantial fall in profitability, with a 62.39% decrease in profit. The company's net worth dipped by a decrease of 7.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Hyrio Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,715,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 May 2013 | Others | ₹0.72 M | Open |
| 10 May 2012 | The Bharat Co-Operative Bank (Mumbai) Limited | ₹1.50 M | Open |
| 10 May 2012 | The Bharat Co-Operative Bank(Mumbai) Ltd | ₹3.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Hyrio Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Hyrio Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyrio Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Hyrio Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Hyrio Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
A charge with Others of Rs. 0.72 M registered on 21 May 2013 with Charge ID 10430514 was modified on 27 Mar 2018. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.72 M with Charge ID 10430514 was registered on 21 May 2013. was completed.
A charge with The Bharat Co-Operative Bank(Mumbai) Ltd of Rs. 3.50 M registered on 10 May 2012 with Charge ID 10357284 was modified on 21 May 2013. was recorded as a recent event.
Progress on A charge with The Bharat Co-Operative Bank (Mumbai) Limited amounted to Rs. 1.50 M with Charge ID 10357280 was registered on 10 May 2012. was documented.
The CIN of Hyrio Laboratories Private Limited is U51397MH2008PTC185185.
Hyrio Laboratories Private Limited is headquartered at 302, Swastik Disa Corporate Park , L. B. S. Marg., Opp. Shreyas Cinema, Ghatkopar (W),, Mumbai, Maharashtra, 400086.
Hyrio Laboratories Private Limited was incorporated on 29 July 2008.
The current directors of Hyrio Laboratories Private Limited are
The primary industry of Hyrio Laboratories Private Limited is Hospital And Medical Care.
Hyrio Laboratories Private Limited is unlisted.
The authorized capital of Hyrio Laboratories Private Limited is ₹2.50 M, and the paid-up capital is ₹0.70 M.
The compliance status of Hyrio Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX